Comment on CMS-2026-1255-0001

Summary: Amazon.com, Inc. supports the proposed rule's efforts to improve medication access through standards-based APIs and electronic prior authorization. However, the company argues that CMS should move away from dual-track standards and instead adopt a single, consistent FHIR-based framework for both medical and pharmacy benefit prior authorizations to reduce complexity and costs.